Korean Drug Co. Ltd (014570) — Cash Flow Reinvestment Rate
Korean Drug Co. Ltd (014570) has a Cash Flow Reinvestment Rate of 0.77x as of September 2025, reinvesting ₩2.86 Billion (capex ₩67.38 Million plus investments ₩2.79 Billion) from operating cash flow of ₩3.72 Billion. Explore reinvestment intensity of Korean Drug Co. Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Korean Drug Co. Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for Korean Drug Co. Ltd across 10 annual periods. Also explore Korean Drug Co. Ltd (014570) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Korean Drug Co. Ltd (2014–2024)
Year-by-year capital reinvestment analysis for Korean Drug Co. Ltd. For live market cap and broader valuation context, see Korean Drug Co. Ltd (014570) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.45x | ₩11.93 Billion | ₩4.87 Billion | ₩1.04 Billion | ▲ +107.4% |
| 2022 | 1.18x | ₩6.99 Billion | ₩5.91 Billion | ₩6.09 Billion | ▲ +28.1% |
| 2021 | 0.92x | ₩8.13 Billion | ₩8.81 Billion | ₩1.15 Billion | ▲ +6.8% |
| 2020 | 0.86x | ₩10.65 Billion | ₩12.33 Billion | ₩738.47 Million | ▲ +27.3% |
| 2019 | 0.68x | ₩4.21 Billion | ₩6.21 Billion | ₩3.05 Billion | ▲ +19.6% |
| 2018 | 0.57x | ₩3.28 Billion | ₩5.79 Billion | ₩1.30 Billion | ▼ -88.1% |
| 2017 | 4.78x | ₩2.14 Billion | ₩447.20 Million | ₩1.13 Billion | ▲ +1240.0% |
| 2016 | 0.36x | ₩1.41 Billion | ₩3.96 Billion | ₩460.84 Million | ▲ +21.1% |
| 2015 | 0.29x | ₩1.81 Billion | ₩6.13 Billion | ₩878.05 Million | ▲ +143.8% |
| 2014 | 0.12x | ₩539.06 Million | ₩4.46 Billion | ₩538.19 Million | — |